C
리브스메드
491000KOSDAQ의료용 기기 제조업44.0 / 100
Reference Date: 2026-04-13
Financial Score13.5 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 27.2% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Livsmed develops, manufactures, and sells laparoscopic surgical instruments for minimally invasive surgery, leveraging its proprietary 90° multi-joint technology to offer products like ArtiSential and ArtiSeal. The company has obtained major international certifications and aims to provide comprehensive solutions in the global minimally invasive surgery market.
Number of Employees
334people
Average Salary
44.3M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 26.524.0Point
PBR
8.91Industry Average 1.700.0Point
5.2x industry avg (risky)
ROE
-20.75Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
4.02Industry Average 10.956.5Point
Half of industry avg (excellent)
Trend 3.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
0.0 / 4
Detailed News Sentiment
1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50
- Neutral밸류보다 성장성…타임폴리오의 투자 기준은 ‘숫자’
타임폴리오자산운용이 비상장 기업 투자 시 매출과 성장성을 중심으로 접근한다는 내용의 인터뷰 뉴스입니다.
Detailed Momentum
52-week position5.0Point
52w mid range (40%)
Current 64,600Won52-week high 91,30052-week low 46,250
1-month return0.0Point
1m -27.17% (strong drop)
Volume trend3.0Point
Volume flat
Detailed Disclosure
7 totalPositive 0Neutral 7Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-04-07
- Neutral정기주주총회결과2026-03-31
- Neutral감사보고서제출2026-03-23
- Neutral사업보고서 (2025.12)2026-03-23
- Neutral주주총회소집공고2026-03-16